San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Qualcomm Predicts Clear Sailing Despite Choppy Waters

We are leading the way to 5G. We’re expanding to more corners of the smartphone. Choppy waters? We’ve sailed through them before.

By Brad Graves April 20, 2017 12:49 p.m.   $$ Share
Tease photo

Robert E. Hoffman Named CFO at Heron Therapeutics

Local biotech Heron Therapeutics Inc. has recruited Robert E. Hoffman, a longtime Arena Pharmaceuticals executive, to serve as Heron’s new chief financial officer and senior vice president of finance.

By Brittany Meiling April 24, 2017 3:55 p.m. share »

Arena Pharmaceuticals Raises $79.4M in Common Stock Offering

Local drugmaker Arena Pharmaceuticals has raised $79.4 million in an offering of its common stock, the company announced April 21.

By Brittany Meiling April 21, 2017 2:50 p.m. share »
Tease photo

Scripps Health Sells Former Hospice Property in Hillcrest for $20 Million

San Diego’s Scripps Health has sold a former hospice facility that it owns in Hillcrest to a Houston-based investment company for $20 million. Camden USA Inc. plans to build a multifamily project on the eight-acre property at 4311 Third Ave., according to CoStar Group and public data.

By Lou Hirsh April 20, 2017 4:57 p.m. share »

Mast Merger Vote Faces Delay

Mast Therapeutics Inc., a local public biotech in the process of being acquired by Austin-based Savara Inc., may have to postpone its meeting to vote on the planned merger.

By Brittany Meiling April 20, 2017 4:47 p.m. share »

IriSys' Deal with National Cancer Institute Doubles to $6 Million

Local drugmaker IriSys LLC announced Thursday that its contract with the National Cancer Institute (NCI) has doubled in value from $3 million to $6 million.

By Brittany Meiling April 20, 2017 3:28 p.m. share »

Ionis Pharmaceuticals to Partner With Chinese Biotech

Carlsbad drugmaker Ionis Pharmaceuticals Inc. has inked a deal with a Chinese biotech that will help Ionis develop and sell its medicines in China.

By Brittany Meiling April 19, 2017 4:25 p.m. share »

Tocagen Inc. Raises $97.8 Million in IPO

San Diego drugmaker Tocagen Inc. ended up raising $97.8 million in an upsized initial public offering this week, making it the largest local IPO since Otonomy’s debut in 2014.

By Brittany Meiling April 19, 2017 2:54 p.m. share »

Drugmaker Tocagen to Raise $85 Million in IPO

San Diego drugmaker Tocagen Inc. plans to raise $85 million in an initial public offering, the company announced Thursday.

By Brittany Meiling April 13, 2017 2:57 p.m. share »

Stock Offering Shakes Investors Confidence in Sorrento Therapeutics

Stock is tanking for local drugmaker Sorrento Therapeutics Inc. following news that it intends to raise $47 million in a public stock offering.

By Brittany Meiling April 13, 2017 2:55 p.m. share »
Tease photo

What's Ex-Google Ventures Exec Up To?

Ex-Google Ventures boss Bill Maris considered launching a $230 million health care fund in late 2016, but ultimately thought better of it. What's he up to?

By Sarah de Crescenzo April 13, 2017 2:52 p.m. share »

Execs Given the ‘Keys’ And Cash for Biotech

Investors have handed the reins of an out-of-state biotech company — along with $40 million in fresh capital — to the former C-suite of San Diego’s short-lived Laguna Pharmaceuticals.

By Brittany Meiling April 13, 2017 1:38 p.m. share »
Tease photo

Persistence Finally Pays Off at Neurocrine Biosciences

The weekend of April 7 was a tense one at the headquarters of Neurocrine Biosciences Inc., where over 300 employees collectively held their breath awaiting word from regulators. A decade-long project was about to make or break the company.

By Brittany Meiling April 13, 2017 1:35 p.m. share »
Tease photo

New Hospital to Meet Challenges, Change

Kaiser Permanente has christened its first new hospital in the San Diego area since 1975, an $850 million facility in Kearny Mesa it says will better integrate care for its 610,000 local members.

By John Cox April 13, 2017 1:31 p.m. share »

Neurocrine's Stock Soars Following FDA Approval of Its Drug Ingrezza

Stock is soaring for San Diego drugmaker Neurocrine Biosciences, which just received a stamp of approval from the U.S. Food and Drug Administration for its lead drug Ingrezza.

By Brittany Meiling April 12, 2017 3:16 p.m. share »

San Diego Behavioral Health Facility Among 6 Being Acquired in $400M Deal

Aurora Behaviorial Health Care San Diego is among six psychiatric hospitals being acquired by Care Capital Properties Inc. in a $400 million deal, the Chicago-based investment company announced.

By Lou Hirsh April 12, 2017 3:14 p.m. share »